Henderson, NV - January 15, 2015 - United Health Products, Inc. (OTCQB: UEEC) announced that it has initiated introduction of its HemoStrip™ line of hemostatic adhesive bandages to major retailers. HemoStrip™ adhesive bandages utilize United Health Products (UHP) patented HemoStyp® Hemostatic Gauze and are available in a variety of sizes. The addition of a hemostatic pad gives HemoStrip™ an advantage over ordinary adhesive bandages which simply absorb blood. The hemostatic material interacts instantly with blood to significantly reduce clotting times and promote healing.
It is estimated that approximately 70% of US households purchase bandages. The US market consists of 115 million households with estimated annual sales of $3 billion.
UHP is concentrating its initial retail efforts on major pharmacy and grocery chains. Initial presentations of HemoStrip™ have been received positively. Packaging and labeling parameters are being addressed and new packaging sent for approval. UHP is confident that retailer orders can be fulfilled within 30 - 45 days upon receipt of a purchase order.
Douglas Beplate, CEO United Health Products, commented, "This is a very exciting time for our Company and our proprietary products. The initial reaction from retailers has been encouraging and we are quickly moving forward. We are optimistic that HemoStrip™ will play an important role in allowing us to meet our retail projections for 2015 of an estimated 5 million dollars."
About United Health Products Inc.
United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com
Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.
United Health Products, Inc.